Dare Bioscience, Inc. SEC filings DARE
Dare Bioscience, Inc. has 777 filings in SEC EDGAR's recent list, going back to May 29, 2007. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 4, 2026 | — |
| S-1 | Registration statement | Aug 26, 2026 | — |
| 424B5 | Prospectus supplement | Aug 17, 2026 | — |
| S-8 | Employee stock plan registration | Jun 23, 2026 | — |
| S-8 | Employee stock plan registration | Aug 14, 2025 | — |
| 424B3 | Prospectus | Nov 26, 2024 | — |
| S-1 | Registration statement | Nov 15, 2024 | — |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| 424B3 | Prospectus | May 1, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Aug 30, 2023 | — |
| 424B5 | Prospectus supplement | Mar 31, 2023 | — |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| S-8 | Employee stock plan registration | Mar 31, 2022 | — |
| 424B5 | Prospectus supplement | Oct 13, 2021 | — |
| 424B5 | Prospectus supplement | Apr 8, 2021 | — |
| S-8 | Employee stock plan registration | Mar 30, 2021 | — |
| S-3 | Shelf registration | Mar 30, 2021 | — |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| 424B3 | Prospectus | Jan 7, 2021 | — |
| S-1/A | Amended registration statement | Jan 5, 2021 | — |
| S-1/A | Amended registration statement | Dec 23, 2020 | — |
| S-1 | Registration statement | Dec 22, 2020 | — |
| 424B5 | Prospectus supplement | Sep 11, 2020 | — |
| 424B5 | Prospectus supplement | Jul 15, 2020 | — |
| 424B3 | Prospectus | Jun 8, 2020 | — |
| 424B3 | Prospectus | May 20, 2020 | — |
| S-3 | Shelf registration | May 15, 2020 | — |
| 424B3 | Prospectus | May 12, 2020 | — |
| S-1 | Registration statement | May 1, 2020 | — |
| 424B5 | Prospectus supplement | May 1, 2020 | — |
| S-8 | Employee stock plan registration | Mar 30, 2020 | — |
| 424B5 | Prospectus supplement | Feb 21, 2020 | — |
| 424B5 | Prospectus supplement | Jan 14, 2020 | — |
| 424B5 | Prospectus supplement | May 31, 2019 | — |
| S-8 | Employee stock plan registration | Apr 10, 2019 | — |
| 424B5 | Prospectus supplement | Apr 10, 2019 | — |
| 424B5 | Prospectus supplement | Apr 8, 2019 | — |
| 424B5 | Prospectus supplement | Sep 26, 2018 | — |
| 424B3 | Prospectus | Sep 25, 2018 | — |
| S-3/A | Filing | Sep 10, 2018 | — |
| S-3 | Shelf registration | Aug 24, 2018 | — |
| S-3 | Shelf registration | Aug 24, 2018 | — |
| S-8 | Employee stock plan registration | Aug 17, 2018 | — |
| 424B5 | Prospectus supplement | Feb 14, 2018 | — |
| 424B5 | Prospectus supplement | Feb 13, 2018 | — |
| 424B5 | Prospectus supplement | Jan 4, 2018 | — |
| 424B5 | Prospectus supplement | Jan 4, 2018 | — |
| 424B5 | Prospectus supplement | Oct 18, 2016 | — |
| POS AM | Form s-3 pos | Oct 13, 2016 | — |
| POS AM | Filing | Aug 5, 2016 | — |
| S-8 | Employee stock plan registration | May 27, 2016 | — |
| S-3 | Shelf registration | Aug 14, 2015 | — |
| S-8 | Employee stock plan registration | May 8, 2015 | — |
| 424B4 | Prospectus | Apr 7, 2015 | — |
| FWP | Free writing prospectus | Apr 7, 2015 | — |
| S-1/A | Amended registration statement | Apr 6, 2015 | — |
| S-1/A | Amended registration statement | Mar 30, 2015 | — |
| S-1 | Registration statement | Mar 20, 2015 | — |
| S-8 | Employee stock plan registration | Aug 13, 2014 | — |
| 424B4 | Prospectus | Apr 14, 2014 | — |
| FWP | Free writing prospectus | Apr 10, 2014 | — |
| S-1/A | Amended registration statement | Mar 31, 2014 | — |
| S-1/A | Amended registration statement | Mar 28, 2014 | — |
| S-1 | Registration statement | Mar 10, 2014 | — |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DARE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1401914
- Former names
- Cerulean Pharma Inc. (until Jul 5, 2017); Tempo Pharmaceuticals Inc (until Jan 22, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.